Abstract
Background: Diabetes mellitus (DM) is a disease of systemic metabolic disorders caused by the decrease of secretion or sensitivity of insulin. In recent years, the study of insulin-related drug targets and the development of new drugs have become the popular topic of current medical research, and studies have shown that multiple signaling pathways are associated with diabetes treatment. At present, some new drugs based on the new target design have been listed on the market and have achieved good hypoglycemic effect. However, most of the drugs are still in the clinical or pre-clinical stage. The efficacy and safety of the drugs need further clinical validation.
Objective: This article will introduce the advancements of targets and drugs to promote insulin secretion.
Keywords: Diabetes mellitus, antidiabetic drugs, GLP-1R, KATP, GPR119, insulin.
Current Pharmaceutical Design
Title:Advances in Antidiabetic Drugs Targeting Insulin Secretion
Volume: 24 Issue: 34
Author(s): Yanting Ding, Yilian Li, Qin Chen*Bing Niu*
Affiliation:
- School of Life Sciences, Shanghai University, Shanghai 200444,China
- School of Life Sciences, Shanghai University, Shanghai 200444,China
Keywords: Diabetes mellitus, antidiabetic drugs, GLP-1R, KATP, GPR119, insulin.
Abstract: Background: Diabetes mellitus (DM) is a disease of systemic metabolic disorders caused by the decrease of secretion or sensitivity of insulin. In recent years, the study of insulin-related drug targets and the development of new drugs have become the popular topic of current medical research, and studies have shown that multiple signaling pathways are associated with diabetes treatment. At present, some new drugs based on the new target design have been listed on the market and have achieved good hypoglycemic effect. However, most of the drugs are still in the clinical or pre-clinical stage. The efficacy and safety of the drugs need further clinical validation.
Objective: This article will introduce the advancements of targets and drugs to promote insulin secretion.
Export Options
About this article
Cite this article as:
Ding Yanting , Li Yilian , Chen Qin*, Niu Bing*, Advances in Antidiabetic Drugs Targeting Insulin Secretion, Current Pharmaceutical Design 2018; 24 (34) . https://dx.doi.org/10.2174/1381612824666181112113756
DOI https://dx.doi.org/10.2174/1381612824666181112113756 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Type 2 Diabetes and Risk for Functional Decline and Disability in Older Persons
Current Diabetes Reviews Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives
Current Medicinal Chemistry Reporting and Interpretation of the CYP2C19 Genotyping Test for Clopidogrel Dosing
Current Pharmacogenomics and Personalized Medicine Intravitreal Inserts of Steroids to Treat Diabetic Macular Edema
Current Diabetes Reviews Meet Our Editorial Board Member (Bioinformatics)
Current Chinese Science Myocardial ‘No-Reflow’ Prevention
Current Vascular Pharmacology An Update on Autoinflammatory Diseases
Current Medicinal Chemistry Hypovitaminosis D is Associated with Endothelial Dysfunction in Patients with Metabolic Syndrome
Current Vascular Pharmacology Many Drugs and Phytochemicals Can Be Activated to Biological Reactive Intermediates
Current Drug Metabolism Aliphatic and Aromatic Oxidations, Epoxidation and S-Oxidation of Prodrugs that Yield Active Drug Metabolites
Current Medicinal Chemistry Gene Therapy for Osteoinduction
Current Gene Therapy Human Imprinting Anomalies in Fetal and Childhood Growth Disorders: Clinical Implications and Molecular Mechanisms
Current Pharmaceutical Design Current Pharmacological Approach to Restore Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry Plasma Non-cholesterol Sterols as Markers of Cholesterol Synthesis and Intestinal Absorption: A Critical Review
Current Pharmaceutical Design A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery Obesity Related Kidney Disease
Current Diabetes Reviews Chronic Pancreatitis and the Development of Pancreatic Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets A Nested Case-Control Study of Serum Fasting Lipid Profiles in Pre- Eclamptic Primigravidas in Ile-Ife, Nigeria
Current Hypertension Reviews Red Wine Consumption and Prevention of Atherosclerosis: An In Vitro Model Using Human Peripheral Blood Mononuclear Cells
Current Pharmaceutical Design The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease
Mini-Reviews in Medicinal Chemistry